BEN-MAIMON CAROLE (President and CEO) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/24/2025ACC: 0001062993-25-001078
DirectorOfficer· President and CEO
Since May 2020
+637K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
637K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+91K
Price / share
—
Trade value
—
% of position
30.7%
1/22/2025
296.21K→387.21K
Total
Net shares
+91K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2025 | A · Award | +91K | — | — | 30.7% | 296.21K | 387.21K |
| Total | +91K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
546K shares
Shares
+546K
Strike price
3.46
Held after
546K
Exercisable
—
1/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock546K shares | 1/22/2025 | A · Award | +546K | 3.46 | — | 546K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned12.25K
Common Stock
IndirectShares owned12.25K
Common Stock
IndirectShares owned12.25K
Total
36.75K indirect36.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.25K | Indirect |
| Common Stock | 12.25K | Indirect |
| Common Stock | 12.25K | Indirect |
| Total | 36.75K | 36.75K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported